Hera Therapeutics Inc.
New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Jun 11, 2015
Total Offering
$15,969,973
Amount Sold
$8,907,483
Investors
26
First Sale
May 27, 2015
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2012
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John Sayward | Related Person |
| Michael Cannon | Related Person |
| William Respess | Related Person |
| Wende Hutton | Related Person |
| David Kabakoff | Related Person |
| Steven James | Related Person |
Company
SEC Filing
0001563355-15-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free